All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0376 | Anti-CDH12 (CBXC-1123) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | Human | CBXC-1123 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3800 | Anti-CDH12 (CBXC-1123) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | Human | CBXC-1123 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2789 | Anti-CDH12 (CBFYC-0022) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-0022 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2790 | Anti-CDH12 (CBFYC-0133) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-0133 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2791 | Anti-CDH12 (CBFYC-1547) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-1547 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6042 | Anti-CDH12 (CBFYC-0022) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-0022 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6043 | Anti-CDH12 (CBFYC-0133) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-0133 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6044 | Anti-CDH12 (CBFYC-1547) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-1547 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0354 | Anti-CDH12 (CBWJC-1788) h(41BB-CD3ζ) CAR, pCDCAR1 | Rabbit | Human | CBWJC-1788 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2646 | Anti-CDH12 (CBWJC-1788) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | Human | CBWJC-1788 | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION